store bpc-157 BPC‑157 — 10 mg | COA-verified peptide BPC-157 Rapid Release - InfiniWell

scar tissue formation at the injury site Anti-inflammatory down-regulates NF-B signaling, one of the key inflammatory pathways active in disc herniations Works in synergy with BPC-157 while BPC-157 creates the growth signals, TB-500 provides the cellular migration framework to execute the repair Protocol: Loading phase: 2.5mg5mg/week subcutaneous injection for 46 weeks Maintenance: 1.252.5mg/week ongoing Frequency: Single weekly injection or split into two 1.25mg injections across the week (both approaches work) The Synergy: Why Run Both Together BPC-157 and TB-500 work through different but complementary mechanisms

Phosphate-buffered saline (PBS): Suitable for short-term in vitro assays requiring a neutral pH environment

Guo Y, Xie J, Rubin E, Tang Y-X, Lin F, Zi X, et al

Medical professionals, including doctors at the prestigious Cleveland Clinic, have been using BPC-157 peptide therapy to help their patients for years